These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11682885)

  • 1. Who caused this tragic medication mistake?
    Crane M
    Med Econ; 2001 Oct; 78(19):49-50, 55-6, 62-3. PubMed ID: 11682885
    [No Abstract]   [Full Text] [Related]  

  • 2. Dana-Farber death sends a warning to research hospitals.
    Roush W
    Science; 1995 Jul; 269(5222):295-6. PubMed ID: 7618095
    [No Abstract]   [Full Text] [Related]  

  • 3. Was the 'wake-up call' from Dana-Farber heard in Europe?
    Ann Oncol; 1995 Oct; 6(8):742-3. PubMed ID: 8589007
    [No Abstract]   [Full Text] [Related]  

  • 4. A near miss involving cyclophosphamide.
    Koczmara C; Broadfield L; Hyland S; Cheng R
    Dynamics; 2009; 20(1):25-6. PubMed ID: 19331060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' concerns about clinical trials in Japan.
    Aoki E
    Lancet; 1999 Mar; 353(9157):1019-20. PubMed ID: 10459946
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of epirubicin and cyclophosphamide in 2-dose levels and classical CMF protocol in node-positive breast cancer. An adjuvant Phase III trial].
    Ost E; Illiger HJ
    Strahlenther Onkol; 2002 Jan; 178(1):54-5. PubMed ID: 11977396
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of smoking history on breast cancer prognosis: retrospective study of 240 operable breast cancer patients who received adjuvant cyclophosphamide, doxorubicin, and 5-fluorouracil chemotherapy regimen.
    Aksoy S; Harputluoglu H; Guler N; Altundag K; Hayran M; Tekuzman G; Ozisik Y
    Breast J; 2007; 13(4):431-2. PubMed ID: 17593056
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral combination chemotherapy with capecitabine and cyclophosphamide in combination with endocrine therapy and anti-HER2 therapy for advanced and metastatic breast cancer].
    Okamura R; Kato T; Sata R
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():592-6. PubMed ID: 23350469
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of advanced breast cancer: How much chemotherapy is enough?
    DiPaola RS; Kaufman A; Mikhail MM
    Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer.
    Pacchiarotti I; Mazzarini L; Pellegrini P; Venturelli V; Sani G; Sánchez-Moreno J; Mancinelli I; Tatarelli R; Kotzalidis GD; Girardi P
    Gen Hosp Psychiatry; 2007; 29(5):461-3. PubMed ID: 17888816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical utility of adjuvant TC regimen].
    Aogi K
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():597-600. PubMed ID: 23350470
    [No Abstract]   [Full Text] [Related]  

  • 12. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
    Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who's to blame for tragic error?
    Grant SM
    Am J Nurs; 1999 Sep; 99(9):9. PubMed ID: 10489569
    [No Abstract]   [Full Text] [Related]  

  • 14. Rocked by highly-publicized medication error, Boston hospital becomes patient safety champion.
    GHA Today; 2001; 45(8):1, 4-5. PubMed ID: 11680407
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
    Valero V
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sequencing of chemotherapy and radiotherapy following breast-preserving treatment of breast carcinoma].
    Sauer R; Martus P
    Strahlenther Onkol; 1996 Sep; 172(9):516-7. PubMed ID: 8928060
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma.
    Gebbia V; Boussen H; Valerio MR
    Anticancer Res; 2012 Feb; 32(2):529-36. PubMed ID: 22287742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personal paper: the scapegoating of a consultant orthopaedic surgeon.
    Crawford DH
    BMJ; 1997 Feb; 314(7078):435-6. PubMed ID: 9040393
    [No Abstract]   [Full Text] [Related]  

  • 19. Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer.
    Nabholtz JM; Smylie M; Mackey JR; Noel D; Paterson AH; al-Tweigeri T; Au D; Sansregret E; Delorme F; Riva A
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):37-41. PubMed ID: 9364541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose cyclophosphamide associated with hemorrhagic cystitis in a breast cancer patient.
    Marshall A; McGrath C; Torigian D; Papanicolaou N; Lal P; Kaplan Tweed C
    Breast J; 2012; 18(3):272-5. PubMed ID: 21972971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.